Biomx Inc logo

PHGE - Biomx Inc News Story

$6.35 -0.4  -5.8%

Last Trade - 6:41pm

Sector
Healthcare
Size
Small Cap
Market Cap £257.1m
Enterprise Value £216.2m
Revenue £n/a
Position in Universe 3941st / 6851

BRIEF-Biomx Reports Third Quarter 2020 Financial Results And Announces Expanded Portfolio Of Phage Therapy Candidates

Thu 12th November, 2020 11:35am
Nov 12 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND
ANNOUNCES
EXPANDED PORTFOLIO OF PHAGE THERAPY CANDIDATES
    * BIOMX INC - ANNOUNCES EXPANDED PORTFOLIO OF PHAGE THERAPY
CANDIDATES
    * BIOMX INC - EXPECTS TO INITIATE A PHASE 2 COSMETIC
CLINICAL
STUDY OF PHAGE THERAPY BX001 IN Q1 OF 2021
    * BIOMX INC -  RESULTS EXPECTED IN Q2 OF 2021 FROM PHASE 2
COSMETIC CLINICAL STUDY OF PHAGE THERAPY BX001
    * BIOMX INC - CASH, EQUIVALENTS, SHORT-TERM DEPOSITS ARE
EXPECTED
TO BE SUFFICIENT TO FUND CURRENT OPERATING PLAN THROUGH MID-2022

Source text for Eikon:  ID:nBw7cMjPla 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.